|本期目录/Table of Contents|

[1]徐元平,杨 辉,魏继红,等.重症肺炎临床特点及其并发抗生素相关性腹泻的临床分析[J].中华肺部疾病杂志,2021,(04):472-474.[doi:10.3877/cma.j.issn.1674-6902.2021.04.017]
点击复制

重症肺炎临床特点及其并发抗生素相关性腹泻的临床分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年04期
页码:
472-474
栏目:
临床研究
出版日期:
2021-08-20

文章信息/Info

Title:
-
作者:
徐元平; 杨 辉; 魏继红; 梅海霞; 唐玉珍
242000 安徽,安徽省宣城市人民医院重症医学科
Author(s):
-
关键词:
重症肺炎;  老年人;  临床特点;  抗生素相关性腹泻;  危险因素
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2021.04.017
摘要:
目的 分析重症肺炎(SP)临床特点及其并发抗生素相关性腹泻(AAD)危险因素。方法 选取2018年7月至2020年10月我院收治的67例细菌性SP患者为对象,统计细菌性SP临床特点及AAD发生情况,采用Logistic回归分析影响细菌性SP患者并发AAD的危险因素。结果 细菌性SP患者临床特征多样,多表现为咳嗽、呼吸困难、咳痰、发热,肺部多见水泡音。67例细菌性SP患者中,19例(28.36%)并发AAD。Logistic多因素回归分析显示抗生素长时间使用、联用抗生素; 应用阿莫西林/克拉维酸是影响细菌性SP患者并发AAD的危险因素[OR(95%CI)分别为3.370(1.387～8.191),4.067(1.674～9.885),3.967(1.632～9.641),P均<0.05]。结论 细菌性SP患者临床特征多样,并发AAD风险高,抗生素长时间使用、联用抗生素、应用阿莫西林/克拉维酸是影响细菌性SP患者并发AAD的危险因素。
Abstract:
-

参考文献/References:

1 Bhattacharyya M, Debnath AK, Todi SK. Clostridium difficile and antibiotic-associated diarrhea[J]. Indian J Crit Care Med, 2020, 24(4): 162-167.
2 Agamennone V, Krul CAM, Rijkers G, et al. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in the netherlands[J]. BMC Gastroenterol, 2018, 18(1): 103-106.
3 Kolodziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial[J]. Clin Microbiol Infect, 2019, 25(6): 699-704.
4 Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis[J]. JAMA, 2018, 307(18): 1959-1969.
5 Silverman MA, Konnikova L, Gerber JS. Impact of antibiotics on necrotizing enterocolitis and antibiotic-associated diarrhea[J]. Gastroenterol Clin North Am, 2017, 46(1): 61-76.
6 李小雅, 陈 静, 刘 洋, 等. 健脾祛湿法调节肠道菌群治疗抗生素相关性腹泻思路探讨[J]. 四川中医, 2020, 38(1): 27-29.
7 Squellati R. Evidence-based practice in the treatment for antibiotic-associated diarrhea in the intensive care unit[J]. Crit Care Nurs Clin North Am, 2018, 30(1): 87-99.
8 Dinleyici M, Vandenplas Y. Clostridium difficile colitis prevention and treatment[J]. Adv Exp Med Biol, 2019, 11(25): 139-146.
9 孔 凡, 黄煦霞, 朱颖亮. 乌梅丸治疗老年抗生素相关性腹泻临证体会[J]. 中医药信息, 2019, 36(1): 65-67.
10 陈 璐, 胡亚惠, 王钦先, 等. 高龄肺部感染病人抗生素相关性腹泻的临床观察[J]. 实用老年医学, 2019, 33(11): 92-94.
11 中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107.
12 McFarland LV, Ozen M, Dinleyici EC, et al. Comparison of pediatric and adult antibiotic-associated diarrhea and clostridium difficile infections[J]. World J Gastroenterol, 2017, 22(11): 3078-104.
13 Kim MA, Park JS, Lee CW, et al. Pneumonia severity index in viral community acquired pneumonia in adults[J]. PLoS One, 2018, 14(3): 102-109.
14 Singh P, Pathak S, Sharma RM. A comparison of acute physiology and chronic health evaluation Ⅲ and simplified cute physiology score Ⅱ in predicting sepsis outcome in intensive care unit[J]. Anesth Essays Res, 2018, 12(2): 592-597.
15 Mullish BH, Williams HR. Clostridium difficile infection and antibiotic-associated diarrhoea[J]. Clin Med, 2018, 18(3): 237-241.
16 Dai M, Liu Y, Chen W, et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients[J]. Crit Care, 2019, 23(1): 324-327.
17 Iwamoto H, Abe M, Yang Y, et al. Cancer lipid metabolism confers antiangiogenic drug resistance[J]. Cell Metab, 2018, 28(1): 104-117.
18 Alberda C, Marcushamer S, Hewer T, et al. Feasibility of a lactobacillus casei drink in the intensive care unit for prevention of antibiotic associated diarrhea and clostridium difficile[J]. Nutrients, 2018, 10(5): 539-542.
19 何彦琪. 30例重症肺炎的临床特点及死亡危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(6): 479-481.
20 谢 云, 王瑞兰. 流感季节重症肺炎救治观念[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(3): 261-264.

备注/Memo

备注/Memo:
基金项目: 安徽省科技计划项目(1706c08532)
通信作者: 徐元平, Email: h456329@126.com
更新日期/Last Update: 2021-08-20